Indian airlines are staring at a revenue loss of Rs 1.1-1.3 lakh crore over three financial years, including the current fiscal, due to the coronavirus pandemic which has led to visa and travel restrictions, thereby severely affecting aviation industry across the world, according to a report.
Airlines are unlikely to recoup this loss as growth is not expected to return to pre-pandemic levels of double-digit increase at least in the medium term, CRISIL Research said.
"Indian airlines are staring at a massive Rs 1.1-1.3 lakh crore revenue forgone over fiscals 2020 to 2022 due to pandemic," the report stated.
One would have assumed that the expected plunge in crude oil prices to $38-42 per barrel in fiscal 2021 compared with $64-66 per barrel in fiscal 2020 would have helped airline companies to an extent on the margin front as it forms a sizeable 30-45 percent of an airline's cost base, it said.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
However, because of the outsized impact of the demand destruction, airlines are curtailing capacity deployment, thereby restricting opportunities to accrue the benefit of low crude oil prices, the report added.
Airlines are projected to post losses at Ebitdar as well as Ebitda levels in fiscal 2021 as fixed costs, such as lease rentals, employee expenses and maintenance tasks, had to be met even when the airplanes were grounded, according to CRISIL.
Curtailed mobility of people due to the COVID-19 pandemic and related restrictions will shrink domestic air passenger traffic by 40-45 percent and international traffic by 60-65 percent, respectively, this fiscal, the report said.
With the COVID-19 pandemic still raging in much of the world, a revival to pre-pandemic levels appears unlikely even next fiscal, it said.
This is a serious jolt to the Indian domestic air travel industry that had logged double-digit growth in seven of the past ten fiscals before its fortunes took a turn for the worse with the bankruptcy and grounding of a couple of major carriers, the report added.
Expecting the domestic passenger traffic to be 78-83 million this fiscal, similar to fiscal 2016, CRISIL said domestic demand could see an increase in Q3/Q4 owing to the festive season, although it will still be lower on-year.
Looking into fiscal 2022, CRISIL does not see the traffic situation improving unless the pandemic is brought under control, it said.
According to CRISIL, ticket prices on domestic routes, which are currently under a fixed cap till August 24, are expected to come off from the third quarter and will on average be lower on-year this fiscal.
However, air fares may rise 4-6 percent on-year on international routes despite low passenger traffic volume.
Delayed resumption of international operations is likely to translate into a steep drop in passenger numbers for fiscal 2021, which may be at fiscal 2008 level at 25-30 million, it said.
While international operations are expected to resume in August (which were grounded from March 23), there is uncertainty with regard to granting of air travel permissions by different countries and because of visa application backlog, it said.
The share of Indian carriers in international traffic is set to rise to 40-42 percent in fiscals 2021 and 2022 from around 36 percent over fiscals 2016 to 2020 as travellers are likely to prefer short to medium haul destinations owing to lower incidence of COVID-19 cases in neighbouring countries, preference for direct flights over transit through hubs and lower trip costs, which can all be served by Indian carriers, CRISIL Research stated.
The pandemic is bound to affect the net fleet addition of Indian carriers, which had about 900 aircraft on order as on March 31, because traffic is unlikely to rebound to even fiscal 2020 level in the medium term and fleet additions are likely to be limited to fleet replacement, with newer generation aircraft replacing older generation leased aircraft, CRISIL said.Follow our full coverage of the coronavirus pandemic here.